The Vexev and U.S. Renal Care teams successfully completed enrollment in the CANSCAN trial. The study is evaluating the use of semi-autonomous ultrasound scanning with the VxWave Ultrasound Imaging ...

Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, today ...

Vexev, an Australian-based medical device company advancing next-generation vascular imaging, and U.S. Renal Care, a leading provider of in-center and home dialysis in the United States, today ...

U.S. Renal Care, the fastest-growing dialysis provider in the nation, partners with nephrologists across 32 states in the U.S. to care for more than 36,000 people living with kidney disease.

A multidrug regimen containing brentuximab vedotin (BV, Adcetris) proved feasible for older patients with advanced classical Hodgkin lymphoma (cHL), with outcomes similar to younger patients but ...

Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant options, thanks to new policy allowing doctors to use co ...

Patients with relapsed/refractory (R/R) follicular lymphoma reported consistent or increased response rates, survival benefits, and health-related quality of life (HRQOL) when taking epcoritamab ...

ALLO-316 shows promising response rates in advanced renal cell carcinoma, utilizing Dagger technology for enhanced CAR T cell efficacy. Quiver AI Summary Allogene Therapeutics has announced ...

A phase I/II trial of high-dose methotrexate (HDMTX) followed by prophylactic glucarpidase in patients with impaired renal function and central nervous system lymphoma (CNSL).. If you have the ...